phase 2_completion
saveEuropean and Developing Countries Clinical Trials Partnership — (diphtheria + tetanus + pertussis (whole cell) + hepatitis B + haemophilus influenzae [serotype B]) vaccine (Phase II Trial Completion)
April 27, 2026(diphtheria + tetanus + pertussis (whole cell) + hepatitis B + haemophilus influenzae [serotype B]) vaccineupdated 4mo ago
community read0 votes
Therapy area: Infectious Disease. Indication: Salmonella Infections